- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07848451
Physiotherapy Exercise Programme for Pelvic Floor Function in Healthy Young Women
A Physiotherapy Exercise Programme Based on Hypopressive Exercise as Adjunctive Muscle Training for the Primary Prevention of Pelvic Floor Dysfunction
This study evaluated the effects of a 12-week physiotherapy exercise programme on pelvic floor and abdominopelvic function in healthy young nulliparous women. Participants were randomly allocated to an intervention group or a control group. The intervention included supervised and home-based exercises focused on postural organization, breathing coordination, and lumbopelvic-abdominal muscle control. The control group continued their usual activities without receiving the study intervention. Pelvic floor muscle function, abdominopelvic functional responses, respiratory function, and health-related quality of life were assessed.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Female university students aged 18 to 26 years.
- Nulliparous.
- No gynecological pathology.
- No respiratory pathology.
- History of sexual intercourse.
Exclusion Criteria:
- Failure to meet any of the inclusion criteria.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Intervention Group
Participants assigned to this group completed a 12-week physiotherapy exercise programme focused on postural organization, breathing coordination, and lumbopelvic-abdominal muscle control, combining supervised sessions with home-based exercise. |
Participants completed a 12-week exercise programme combining postural organization, breathing coordination, and lumbopelvic-abdominal motor control. The programme included a 20-minute supervised session once weekly, complemented by home-based exercise. |
|
Sin intervención: Control group
Participants assigned to this group continued their usual activities and did not receive the study exercise programme during the 12-week study period. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Subumbilical Cough Test
Periodo de tiempo: Baseline and after the 12-week intervention
|
Qualitative assessment of abdominal wall response during coughing. The outcome was categorized as no bulging or bulging of the abdominal wall. Bulging was defined as caudal bulging of the umbilicopubic region during the cough maneuver, indicating insufficient abdominal muscle activation. |
Baseline and after the 12-week intervention
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Pelvic Floor Muscle Strength - Modified Oxford Scale
Periodo de tiempo: Baseline and after the 12-week intervention
|
Pelvic floor muscle strength was assessed by digital vaginal palpation using the Modified Oxford Scale, scored from 0 to 5, where 0 indicates no perceptible muscle contraction and 5 indicates a strong contraction. |
Baseline and after the 12-week intervention
|
|
Pelvic Floor Muscle Endurance
Periodo de tiempo: Baseline and after the 12-week intervention
|
Pelvic floor muscle endurance was assessed by vaginal perineometry. Participants performed three maximal pelvic floor muscle contractions, each maintained for as long as possible. Endurance was recorded as the duration of the sustained contraction, expressed in seconds. |
Baseline and after the 12-week intervention
|
|
Pelvic Floor Muscle Contraction Pressure
Periodo de tiempo: Baseline and after the 12-week intervention
|
Pelvic floor muscle contraction pressure was assessed by vaginal perineometry using a pressure probe. Participants performed three maximal pelvic floor muscle contractions, and contraction pressure was recorded in cmH2O. |
Baseline and after the 12-week intervention
|
|
Abdominal Diastasis Functional Test
Periodo de tiempo: Baseline and after the 12-week intervention
|
Abdominal wall function was assessed by palpation of the linea alba in the supraumbilical and infraumbilical regions, at rest and during trunk elevation. The test evaluated the presence or absence and location of abdominal diastasis and the response of the linea alba during abdominal muscle activation. |
Baseline and after the 12-week intervention
|
|
Transversus Abdominis Activation Test
Periodo de tiempo: Baseline and after the 12-week intervention
|
Abdominal wall response was assessed during maximal inspiration and expiration. During maximal expiration, the outcome was categorized according to whether the abdomen protruded ("pushes") or did not protrude ("does not push"), reflecting the activation response of the transversus abdominis. |
Baseline and after the 12-week intervention
|
|
Forced Vital Capacity (FVC)
Periodo de tiempo: Baseline and after the 12-week intervention
|
Forced vital capacity was assessed by forced spirometry using a DATOSPIR-120 spirometer. Three measurements were performed and the best measurement was recorded. FVC was expressed in liters. |
Baseline and after the 12-week intervention
|
|
Forced Expiratory Volume in One Second (FEV1)
Periodo de tiempo: Baseline and after the 12-week intervention
|
Forced expiratory volume in one second was assessed by forced spirometry using a DATOSPIR-120 spirometer. Three measurements were performed and the best measurement was recorded. FEV1 was expressed in liters. |
Baseline and after the 12-week intervention
|
|
Peak Expiratory Flow (PEF)
Periodo de tiempo: Baseline and after the 12-week intervention
|
Peak expiratory flow was assessed by forced spirometry using a DATOSPIR-120 spirometer. Three measurements were performed and the best measurement was recorded. PEF was expressed in liters per second (L/s). |
Baseline and after the 12-week intervention
|
|
Health-Related Quality of Life - SF-12
Periodo de tiempo: After the 12-week intervention
|
Health-related quality of life was assessed using the 12-item Short Form Health Survey (SF-12). Physical and mental health component scores were calculated, with higher scores indicating better perceived health-related quality of life. |
After the 12-week intervention
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Luís Gómez Pérez, PhD, Universidad Miguel Hernández
Publicaciones y enlaces útiles
Publicaciones Generales
- Sirvent-Pinar MA, Iglesias-Comesaña A, Guerrero-Rubio MA, Alarcón-Alarcón D, Rodríguez-Blanco N, Pérez de Arrilucea Le Floc'h U. Development and reproducible description of a multimodal physiotherapy intervention for pelvic floor health: a methodological report. BMC Women's Health. 2026. doi:10.1186/s12905-026-04779-3.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- DPC.LGP.01.17
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
No prospective plan for individual participant data sharing was established for this study.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .